# Charles River Laboratories Executive Shannon M. Parisotto Sells $742,547.96 in Common Shares

> Charles River Laboratories executive Shannon M. Parisotto sold 2,156 common shares for $742,547.96 and exercised 2,156 options.

- Published: 2026-10-24T00:19:59+00:00
- Section: Business
- Author: News Desk
- URL: https://newsforagent.com/news/2026-10-24/charles-river-executive-share-sale
- Source: [The future of trading](https://capital.com/en-int/news/charles-river-laboratories-cevp-discovery-safety-assessment-shannon-m)

## Key takeaways

- Shannon M. Parisotto sold 2,156 Charles River Laboratories common shares at $344.41 on October 21, 2026.
- Parisotto exercised 2,156 stock options at $244.41 per share the same day, leaving 719 options.
- After the transactions, Parisotto held 4,807 shares directly, 28,510 through Karpathos Investments LLC and 9,680 through a trust.

[Charles River Laboratories International](https://akta.pro/company-profiles/0000c1w/charles-river-laboratories-international)'s chief executive vice president for Discovery & Safety Assessment, Shannon M. Parisotto, sold 2,156 common shares at $344.41 on October 21, 2026, a transaction worth $742,547.96, and exercised 2,156 stock options at $244.41 per share that day. [The future of trading](https://capital.com/en-int/news/charles-river-laboratories-cevp-discovery-safety-assessment-shannon-m) reported the sale.

## Parisotto's Share Sale and Option Exercise

Parisotto's sale of 2,156 common shares at $344.41 produced the $742,547.96 total. She also exercised 2,156 stock options at $244.41 per share on the same date, leaving 719 options outstanding.

Following the transactions, her holdings totaled 4,807 shares directly, 28,510 shares through Karpathos Investments LLC and 9,680 shares through a trust. Charles River Laboratories International is a Wilmington-based contract research organization founded in 1947 that provides nonclinical testing, research models and manufacturing support to pharmaceutical and biotechnology companies, according to [company records](https://akta.pro/company-data).

## Charles River's Recent Partnerships and Divestitures

Charles River launched a collaboration with Eli Lilly's TuneLab AI/ML drug discovery platform in June 2026 to provide nonclinical testing and help standardize testing protocols through federated learning, according to akta.pro company records. In May 2026, GI Partners completed its acquisition of the Contract Development and Manufacturing Organization and Cell Solutions businesses from Charles River for approximately $145 million, forming a new standalone company called Rose BioSolutions focused on end-to-end cell and gene therapy services.

Charles River also entered a partnership with Deciphex in May 2026 for AI-powered digital pathology using the Patholytix and Foresight platforms, which reduces read times by 20% and improves pathologist efficiency by 30%. The company operates more than 130 facilities in 30 countries.

## Earlier Charles River Developments

On October 6, 2026, Charles River and Autolomous launched Apollo Orchestrate, a digital laboratory execution capability within Charles River's Apollo platform that connects sample submission, execution and review into one digital workflow, shifting records from paper to digital, MarketScreener reported. On October 5, 2026, American Banking and Market News reported that analysts had updated their ratings and price targets for Charles River, with UBS upgrading to strong-buy and setting a $357 target, while insiders sold 90,990 shares in 90 days.

On October 4, 2026, Simply Wall St reported that Charles River shares rose 63.6% over the past year, trading at $290, while revenue fell from $1,032.1m to $1,004.1m and net margin turned negative.

## What to Watch Next

Charles River has guided full-year 2026 revenue to a range of $3.879 billion to $3.920 billion and adjusted EPS to $10.80 to $11.30, according to company records. Management targets $11.15 to $11.45 EPS for the year.

## Companies in this story

- [Charles River Laboratories International company profile](https://akta.pro/company-profiles/0000c1w/charles-river-laboratories-international) · website: http://www.criver.com

---
News for Agent · https://newsforagent.com/llms.txt